O Turrini
Overview
Explore the profile of O Turrini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
360
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Droeser R, Kaneva P, Cheng V, Lam L, Benjamin E, Matsushima K, et al.
Can J Surg
. 2022 Apr;
61(4 Suppl 1):S94-S174.
PMID: 35488393
No abstract available.
2.
Mattevi C, Garnier J, Marchese U, Ewald J, Gilabert M, Poizat F, et al.
BMC Surg
. 2020 Aug;
20(1):176.
PMID: 32758203
Purpose: To determine if improvement in imaging reduces the non-resection rate (NRR) among patients with pancreatic ductal adenocarcinoma (PDAC). Methods: From 2000 to 2019, 751 consecutive patients with PDAC were...
3.
Delpero J, Veran O, Turrini O, Pessaux P
J Visc Surg
. 2020 Mar;
157(2):75-77.
PMID: 32178933
No abstract available.
4.
Medrano J, Garnier J, Ewald J, Marchese U, Gilabert M, Launay S, et al.
Pancreatology
. 2019 Dec;
20(2):223-228.
PMID: 31839458
Background/objective: We evaluated the usefulness of the 2017 definition of borderline pancreatic ductal adenocarcinoma (BR-PDAC) in fit patients (performance status 0-1) based on anatomical (A) and biological dimensions (B). Methods:...
5.
Marchese U, Ewald J, Gilabert M, Delpero J, Turrini O
J Visc Surg
. 2018 Jul;
156(2):97-101.
PMID: 30026012
Purpose: Survival appears to be poor in cases of pancreatic ductal adenocarcinoma (PDAC) with para-aortic lymph node involvement (PALN+). However, resection is still performed in these cases because the prognostic...
6.
Vanbrugghe C, Tabchouri N, Louis G, Del Grande J, Lagrange X, Turrini O, et al.
J Gastroenterol Hepatol
. 2018 Feb;
33(3):563.
PMID: 29469233
No abstract available.
7.
Maignan A, Ouaissi M, Turrini O, Regenet N, Loundou A, Louis G, et al.
J Visc Surg
. 2018 Feb;
155(3):173-181.
PMID: 29396112
Patients And Methods: Between January 1, 2014 and June 19, 2015, 91 consecutive patients undergoing pancreatoduodenectomy (PD) or left pancreatectomy (LP) (72% and 28%, respectively) were followed prospectively. ExoPI was...
8.
Turrini O, Gilabert M, Ewald J, Moutardier V, Delpero J, Iovanna J
J Visc Surg
. 2017 Aug;
154(5):329-333.
PMID: 28844705
Purpose: To assess the K-ras gene mutation in the histologically negative venous margin of a pancreaticoduodenectomy (PD) specimen and its impact on survival. Method: From 2007 to 2010, 22 patients...
9.
Duconseil P, Perinel J, Autret A, Adham M, Sauvanet A, Chiche L, et al.
Eur J Surg Oncol
. 2017 Jul;
43(9):1704-1710.
PMID: 28687431
Purpose: To compare survival and impact of adjuvant chemotherapy in patients who underwent pancreaticoduodenectomy (PD) for invasive intraductal papillary mucinous neoplasm (IIPMN) and sporadic pancreatic ductal adenocarcinoma (PDAC). Methods: From...
10.
Duconseil P, Turrini O, Ewald J, Soussan J, Sarran A, Gasmi M, et al.
HPB (Oxford)
. 2015 Feb;
17(6):485-9.
PMID: 25691074
Objective: To assess the accuracy of pre-operative staging in patients with peripheral pancreatic cystic neoplasms (pPCNs). Methods: From 2005 to 2011, 148 patients underwent a pancreatectomy for pPCNs. The pre-operative...